[Federal Register: April 4, 2005 (Volume 70, Number 63)]
[Notices]
[Page 17094-17095]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ap05-89]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifier: CMS-10008]


Agency Information Collection Activities: Submission for OMB
Review; Comment Request

AGENCY: Centers for Medicare & Medicaid Services, HHS.
    In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the Agency's function; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
    1. Type of Information Collection: Revision of a currently approved
collection; Title of Information Collection: Process and Information
Required to Determine Eligibility of Drugs, Biologicals, and Radio-
pharmaceutical Agents for Transitional Pass-Through Provisions Under
the Hospital Outpatient Prospective Payment System (OPPS) and
Supporting Regulations in 42 CFR, Section 419.43; Use: Section
1833(t)(6) of the Social Security Act provides for temporary additional
payments or ``transitional pass-through payments'' for certain drugs
and biological agents. Interested parties such as hospitals,
pharmaceutical companies, and physicians can apply for transitional
pass-through payment for drugs and biologicals used with services
covered under the OPPS. CMS uses this information to determine if the
criteria for making a transitional pass-through payment are met and if
an interim HCPCS code for a new drug or biological is necessary. The
revisions made to this collection include the addition of Section 303
of the MMA. This new section establishes the use of the average sales
price (ASP) methodology for payment; Form Number: CMS-10008
(OMB 0938-0802); Frequency: On occasion; Affected Public:
Business or other for-profit and Not-for-profit institutions; Number of
Respondents: 58; Total Annual Responses: 58; Total Annual Hours: 203.
    To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS Web
site address at http://www.cms.hhs.gov/regulations/pra/, or e-mail your

request, including your address, phone number, OMB number, and CMS
document identifier, to Paperwork@cms.hhs.gov, or call the Reports
Clearance Office on (410) 786-1326.
    Written comments and recommendations for the proposed information
collections must be mailed within 30 days of this notice directly to
the OMB desk officer: OMB Human

[[Page 17095]]

Resources and Housing Branch, Attention: Christopher Martin, New
Executive Office Building, Room 10235, Washington, DC 20503.

    Dated: March 24, 2005.
John P. Burke, III,
CMS Paperwork Reduction Act Reports Clearance Officer, Office of
Strategic Operations and Regulatory Affairs, Regulations Development
Group.
[FR Doc. 05-6534 Filed 4-1-05; 8:45 am]

BILLING CODE 4120-01-P